Skip to content

Virtual reality-assisted therapy for auditory verbal hallucinations: a multicenter randomized controlled clinical trial

Virtual reality-assisted therapy for auditory verbal hallucinations: a multicenter randomized controlled clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027254
Enrollment
Unknown
Registered
2019-11-06
Start date
2019-11-15
Completion date
Unknown
Last updated
2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Verbal auditory hallucination of mutiple disease

Interventions

Virtual Reality-assisted therapy group:Avatar technology
Therapy-as usual group:Therapy as usual

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. aged over 18 years; 2. have experienced auditory hallucinations; 3. primary diagnosis of Structured Clinical Interview for DSM-V-TR (including Sc1hizophrenia, Major Depressive Disorder, and Bipolar disorder).

Exclusion criteria

Exclusion criteria: 1. unable to give informed consent; 2. currently in receipt of cognitive behaviour therapy for psychosis or attending a group specific to hearing voices; 3. unable to identify a single dominant voice to work on; 4. refusing all medication; 5. a diagnosis of organic brain disease; 6. a primary substance dependency; 7. auditory hallucinations in a language not spoken by the therapists; 8. inability to tolerate the assessment process.

Design outcomes

Primary

MeasureTime frame
Psychotic Symptom Rating Scales, auditory hallucinations subscale, PSYRATS–AH-Total;

Secondary

MeasureTime frame
Psychotic Symptom Rating Scales, auditory hallucinations subscale, PSYRATS–AH;Belief About Voices Questionnaire-Revised, BAVQ-R;

Countries

China

Contacts

Public ContactYong Xu

The First Hospital of Shanxi Medical University

xuyongsmu@vip.163.com+86 18234016125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026